Format

Send to

Choose Destination
Comp Med. 2019 Mar 1;68(2):124-130.

Comparative Review of Antimicrobial Resistance in Humans and Nonhuman Primates.

Author information

1
Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Ohio State University, Columbus, Ohio.
2
Department of Veterinary Preventive Medicine, College of Veterinary Medicine, University of Laboratory Animal Resources, Ohio State University, Columbus, Ohio.
3
California National Primate Research Center, University of California-Davis, Davis, California.
4
Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Ohio State University, Columbus, Ohio;, Email: habing.4@osu.edu.

Abstract

Antimicrobial resistance (AMR) presents serious threats to human and animal health. Although AMR of pathogens is often evaluated independently between humans and animals, comparative analysis of AMR between humans and animals is necessary for zoonotic pathogens. Major surveillance systems monitor AMR of zoonotic pathogens in humans and food animals, but comprehensive AMR data in veterinary medicine is not diligently monitored for most animal species with which humans commonly contact, including NHP. The objective of this review is to provide a complete report of the prevalences of AMR among zoonotic bacteria that present the greatest threats to NHP, occupational, and public health. High prevalences of AMR exist among Shigella, Campylobacter, and Yersinia, including resistance to antimicrobials important to public health, such as macrolides. Despite improvements in regulations, standards, policies, practices, and zoonotic awareness, occupational exposures to and illnesses due to zoonotic pathogens continue to be reported and, given the documented prevalences of AMR, constitute an occupational and public health risk. However, published literature is sparse, thus indicating the need for veterinarians to proactively monitor AMR in dangerous zoonotic bacteria, to enable veterinarians to make more informed decisions to maximize antimicrobial therapy and minimize occupational risk.

PMID:
29631652
PMCID:
PMC5897968
[Available on 2018-10-01]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center